Explore our curated selection of high-quality formulations, sterile liquids, and bioactive molecules. Backed by rigorous quality control, our products satisfy global EP, BP, and USP standards.
Jiangxi Serum Pharma Industries Co., Ltd. stands as a world-class, professional supplier of pharmaceutical APIs, finished dosage formulations, and high-purity nutritional products based in China. Over nearly a decade, we have honed our core capabilities in exporting complex biological formulations, vaccines, Western medicines, critical chemical raw materials, active intermediates, medical consumables, food additives, and premium botanical extracts.
Our mission goes beyond trading; we align global supply chains to demanding clinical specifications. In the category of sterile parenteral injectables, we integrate raw material procurement, formulation validation, aseptic packaging, and comprehensive regulatory documentation. Our deep understanding of global distribution logistics ensures that life-saving therapeutic solutions are delivered securely, promptly, and in compliance with international pharmacopoeia standards.
Cyanocobalamin (Vitamin B12) is an essential organometallic molecule containing cobalt, critical for the synthesis of red blood cells, neurological health, and cellular DNA replication. While oral supplementation is common for basic dietary gaps, clinical management of severe deficiency states—such as pernicious anemia, malabsorption syndromes, peripheral neuropathy, and gastrectomy recovery—demands direct intramuscular or deep subcutaneous Cyanocobalamin Injection.
For global corporate purchasers, hospital procurement groups, and Ministry of Health distributors, sourcing Cyanocobalamin Injection involves multi-layered compliance audits. Procurement departments must secure stable suppliers capable of delivering batches with absolute sterility, high assay accuracy (typically 95.0% to 115.0% of the labeled amount according to USP/EP regulations), and low endotoxin levels. The challenges of international cold chain monitoring, batch consistency, and long-term shelf-life stability make choosing a strategic manufacturing partner paramount.
Production must align with strict USP, BP, or EP specifications. Raw materials undergo high-performance liquid chromatography (HPLC) testing to ensure purity is verified before formulation begins.
Injectables require rigorous LAL (Limulus Amebocyte Lysate) testing to verify that bacterial endotoxins stay well below the threshold of 1.15 USP Endotoxin Units per microgram of Cyanocobalamin.
Supplied in Type I amber glass ampoules or multidose vials protected from light. Light exposure degrades cyanocobalamin into hydroxocobalamin, diminishing therapeutic efficacy.
As the pharmaceutical supply chain encounters shifting global standards, suppliers must implement robust industrial solutions that transcend simple supply-and-demand dynamics. For Cyanocobalamin Injections, this involves providing customizable concentration options (e.g., 100 mcg/mL, 1000 mcg/mL, or veterinary formulations at higher densities) matched with customized stabilizers like sodium chloride and benzyl alcohol (preservative).
| Parameter / Specification | USP Reference Requirement | EP / BP Reference Standard | Serum Pharma Export Solution Range |
|---|---|---|---|
| Assay Content (HPLC) | 95.0% – 115.0% | 96.0% – 102.0% (API) | 98.5% – 101.5% Ultra-Pure Control |
| Bacterial Endotoxins | < 1.15 USP EU/µg | Conforms to limit test | < 0.5 EU/µg (Strict Batch Release) |
| pH Values | 4.5 to 7.0 | 4.5 to 7.0 | 5.0 to 6.5 (Highly Buffered Stability) |
| Particulate Matter | USP <788> compliant | Conforms to Ph. Eur. 2.9.19 | Aseptic Laser-Screened Fill |
| Sterility Testing | No microbial growth detected | Sterile R.5.1.1 | Class A Cleanroom Aseptic Filtration & Fill |
The commercial manufacturing of Cyanocobalamin relies entirely on microbial fermentation, as chemical synthesis is highly complex and financially unviable. Historically, strains such as Pseudomonas denitrificans and Propionibacterium freudenreichii have served as the main production hosts. The technical roadmap for the next decade is moving towards synthetic biology optimization to increase yields and lower ecological footprints.
Researchers are engineering host strains like Escherichia coli and Bacillus subtilis to express the entire 30-step biosynthetic pathway of cobalamin. Modulating rate-limiting enzymes and optimization of cobalt insertion steps are projected to double fermentation yields within the next five years, reducing raw material costs for corporate buyers.
Due to growing clinical concern over benzyl alcohol sensitivity in neonatal and pediatric populations, there is a strong shift toward preservative-free, single-use blow-fill-seal (BFS) technology. This maintains sterility without chemical additives, satisfying the stringent safety requirements of clinical institutions.
Serum Pharma continuously monitors cutting-edge health ingredients, combining traditional plant extraction with advanced biological fermentation methods. Our nutritional ingredients support cellular health, maintain body balance, and optimize physical vitality.
Tailored vitamin and mineral pre-mix designs designed to optimize manufacturing throughput and nutritional profile integration.
Enhancing the solubility, stability, and delivery profile of active components via targeted crystal engineering.
Harnessing optimized micro-organisms to synthesize pure, highly active metabolites in cleanroom conditions.
Due to the light-sensitive nature of Cyanocobalamin, maintaining strict distribution protocol is critical. Injections must be packaged in Class I hydrolytic resistance amber glass and shipped inside climate-controlled shipping containers. We guarantee the structural integrity of the active molecules by implementing continuous temperature logging across sea and air freight routes, eliminating potential thermal or photochemical degradation.
Entering heavily regulated regional markets (such as the EU or FDA zones) requires meticulous administrative preparation. We provide our global partners with fully formatted CTD (Common Technical Document) files, including Active Substance Master Files (ASMF) or DMF (Drug Master Files). This documentation streamlines your local registration process, facilitating faster approvals from local health authorities.
Our quality control protocols comply fully with WHO-GMP guidelines. We assist buyers in scheduling on-site third-party quality audits and coordinate with local laboratory test procedures (such as verifying bio-equivalence and executing sterility studies). By integrating raw material trace logs, intermediate test data, and final batch documentation, we offer complete accountability for all distributed therapeutic injectables.
We understand the critical nature of therapeutic raw material supply. Every batch shipped is validated by independent certificates of analysis (COA), heavy metals screening, and gas chromatography tests, ensuring our clients receive clinical-grade, stable parenteral formulations.
Find expert answers to key technical questions concerning the chemistry, stability, regulatory filing, and global logistics of therapeutic Cyanocobalamin Injections.
Cyanocobalamin is a synthetic, highly stable form of Vitamin B12 that features a cyano group coordinated to the cobalt ion. This structural composition makes it more resistant to heat and oxidation than Methylcobalamin. Methylcobalamin, while biological active, degrades rapidly when exposed to ambient light, making Cyanocobalamin the preferred choice for mass commercial injectables requiring a long-term shelf life.
Cyanocobalamin is photochemically unstable. Exposure to ultraviolet or visible light causes the cleavage of the cobalt-carbon bond, leading to the formation of aquocobalamin or hydroxocobalamin, which reduces the active dosage strength. To prevent this, the formulation must be stored in Type I amber glass containers and protected by outer carton packaging during distribution.
Sterility is maintained by combining initial filtration using 0.22-micron polyethersulfone (PES) membranes with terminal aseptic filling inside Class 100 (ISO 5) cleanroom systems. Regular validation of the media fills, alongside automated validation of the sterilization cycles (F0 calculation), ensures the absence of microbiological contamination.
Multidose formulations typically include 1.5% Benzyl Alcohol as an antimicrobial preservative. For single-dose ampoules, preservatives are omitted to protect patients sensitive to benzyl alcohol, such as newborns or patients undergoing high-dose neurological therapies.
We employ Inductively Coupled Plasma Mass Spectrometry (ICP-MS) to screen raw materials in accordance with the ICH Q3D guidelines for elemental impurities. Cobalt is monitored as the central active constituent, while levels of lead, arsenic, mercury, and cadmium are strictly controlled to ensure they remain well below international safety limits.
We provide a complete CTD dossier, including raw material DMF validation, stability data under zone IVB climatic conditions, validation of the sterilization processes, validation of the analytical methods, and WHO-GMP manufacturing certificates.
When kept below 25°C, away from direct sunlight, and protected from freezing, our formulated injectables maintain a stable shelf life of 36 months, with the active assay remaining well within the required USP/BP parameters.
Yes, it is often combined with Vitamin B1 (Thiamine) and Vitamin B6 (Pyridoxine) to create neurotropic complexes. However, combining these ingredients requires careful pH monitoring, as Thiamine degradation products can accelerate the decomposition of Cyanocobalamin if the pH drifts outside the optimal 4.5 to 5.5 range.
Stay updated on emerging global industry developments, regulatory milestones, and technical breakthroughs across the global healthcare landscape.
An analytical review of the transitioning squalene market. As regulatory bodies enforce sustainable alternatives, plant-derived squalene (sourced from olives and sugar cane) is replacing shark-derived squalene as a critical vaccine adjuvant.
This report reviews the role of Dexamethasone Sodium Phosphate as a highly effective anti-inflammatory agent. We evaluate the manufacturing steps required to keep the free dexamethasone level below international pharmacopoeia standards.
Reviewing the landmark approval of Foundayo™ (orforglipron) by Eli Lilly. The 50-day fast-track process highlights a changing paradigm in therapeutic drug development, drawing industry focus toward innovative small-molecule peptide alternatives.
Browse our secondary catalog containing high-purity biological extracts, anti-aging compounds, and antibiotics optimized for global distribution.
